NCM · Medical - Instruments & Supplies

Bionano Genomics, Inc. (BNGO) Stock

$1.44 -1.71% NCM: BNGO Healthcare

Valuation

MetricValue
Price$1.44
Market Cap$16.47M
P/E Ratio-0.45
P/B Ratio0.61
P/S Ratio0.63
EPS (TTM)$-4.85
52-Week High$2.23
52-Week Low$1.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-78.78%
ROA-67.58%
ROCE-85.72%
Gross Margin46.25%
Operating Margin-107.36%
Net Margin-106.58%
Debt/Equity0.21
Current Ratio1.98

Annual Financials (USD)

Metric20212022202320242025
Revenue$18.0M$28.0M$36.0M$31.0M$29.0M
Operating Profit$-77.0M$-132.0M$-215.0M$-104.0M$-33.0M
Net Profit$-72.0M$-133.0M$-232.0M$-112.0M$-26.0M
EPS$-157.02$-275.09$-408.48$-88.13$-4.85
Op Margin-428.8%-473.7%-596.0%-337.9%-117.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$377.0M$308.0M$214.0M$77.0M$74.0M
Total Liabilities$40.0M$58.0M$118.0M$41.0M$29.0M
Cash$25.0M$5.0M$18.0M$9.0M$3.0M
Borrowings$11.0M$12.0M$79.0M$27.0M$7.0M

Latest News

Nabsys Appoints Genome Mapping Pioneer Alka Chaubey, Ph.D., as Chief Medical and Genomics Officer PR Newswire · Jul 6, 2026 Bionano Announces Hiring of Chief Scientific Officer GlobeNewswire · Jun 24, 2026 Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption GlobeNewswire · Jun 18, 2026 Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders GlobeNewswire · Jun 11, 2026 Bionano Genomics (BNGO) Upgraded to Buy: What Does It Mean for the Stock? Zacks · Jun 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-72.0M$-125.0M$-125.0M$-69.0M$-16.0M
Investing Cash Flow$-280.0M$79.0M$22.0M$74.0M$-13.0M
Financing Cash Flow$8.0M$0$-15.0M$-10.0M$0
Net Cash Flow$-14.0M$-19.0M$13.0M$-9.0M$-5.0M
Free Cash Flow$-73.0M$-128.0M$-127.0M$-69.0M$-16.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.98
FCF Yield-107.52%
Quick Ratio1.96
Interest Coverage-151.12
Return 1Y-64.79%
Return 3Y-99.69%
Return 5Y-99.97%

Ownership

Insiders Held7.41%
Institutions Held10.12%
Institutions Float Held10.93%
Institutional HolderSharesReport Date
GSA Capital Partners LLP353,3632026-03-31
Geode Capital Management, LLC167,5332026-03-31
Carret Asset Management, LLC70,0002026-03-31
Vanguard Capital Management LLC68,1092026-03-31
Vanguard Fiduciary Trust Co51,5782026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Bionano Genomics, Inc.

Bionano Genomics, Inc. is led by CEO Robert Erik Holmlin, employs 98 people, headquartered in US, publicly traded since 2018.

Bionano Genomics, Inc. (BNGO) stock trades at $1.44 with a market capitalization of $16.47M. The stock is valued at a price-to-earnings (P/E) ratio of -0.45, price-to-book of 0.61, price-to-sales of 0.63. Over the past 52 weeks the stock has ranged between $1.00 and $2.23, and currently trades 35.4% below its 52-week high.

On profitability, Bionano Genomics, Inc. generates a return on equity (ROE) of -78.78%, return on capital employed of -85.72%, an operating margin of -107.36%, a net profit margin of -106.58%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides